Lotte Wilke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lotte Wilke has a total of 94 co-authors. Here are the top co-authors by number of shared publications:
- Matthias Guckenberger
Department of Radiation Oncology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland
10 shared publications - Madalyne Day
Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland
7 shared publications Nicolaus Andratschke
5 shared publications- Panagiotis Balermpas
Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland
5 shared publications Stephanie Tanadini-Lang
5 shared publications- Stephanie Tanadini-Lang
Department of Radiation Oncology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland
5 shared publications
Latest Publications
- Open Access
- 6 July 2026
- Published by Springer Nature in Radiation Oncology
- Vol. 21 (1)
MRI-enhanced online adaptive radiotherapy by virtual integration of a standalone MRI simulator and CBCT-based treatment delivery
Background and purpose: MR-guided radiotherapy (MRgRT) offers superior soft-tissue contrast and enables adaptive treatments which improve tumor targeting and organ-at-risk sparing. However, integrated MR-Linac systems remain financially and logistically inaccessible for many hospitals. To address this gap, we implemented a modular MRgRT workflow — termed the “Virtual MR-Linac”— which decouples MR imaging and treatment delivery, enabling daily adaptive radiotherapy (ART) using diagnostic-quality MRI. Materials and methods: Between November 2023 and January 2025, 31 male patients with pelvic lymph node metastases were treated using this workflow. Daily MR scans were acquired in treatment position using a 1.5T MR scanner. Contours were adapted on 2D T2 turbo-spin-echo images, while synthetic CTs generated from T1 DIXON sequences were used for dose calculation. Adapted plans were delivered on a C-arm Linac using CBCT imaging for positioning. Quality assurance included independent Monte Carlo dose recalculations, automated plan parameters verification and a plan complexity check using in-house scripting. Results: Across 99 adapted fractions, plan adaptation improved dosimetric outcomes, with a median 14% increase in Planning Target Volume (PTV) coverage and a 7% reduction in bowel D1cc (dose to 1 cc). Median times for MR imaging, contouring, and planning were 12, 12, and 20 min, respectively. Conclusions: The Virtual MR-Linac approach enables high-quality ART to compensate for inter-fractional motion without the costs and complexity of integrated systems. It improves resource utilization, maintains patient comfort, and offers a flexible, scalable solution for clinical implementation.
- 6 July 2026
- Published by Springer Nature in Radiation Oncology
- Vol. 21 (1)
Open AccessMRI-enhanced online adaptive radiotherapy by virtual integration of a standalone MRI simulator and CBCT-based treatment delivery
Background and purpose: MR-guided radiotherapy (MRgRT) offers superior soft-tissue contrast and enables adaptive treatments which improve tumor targeting and organ-at-risk sparing. However, integrated MR-Linac systems remain financially and logistically inaccessible for many hospitals. To address this gap, we implemented a modular MRgRT workflow — termed the “Virtual MR-Linac”— which decouples MR imaging and treatment delivery, enabling daily adaptive radiotherapy (ART) using diagnostic-quality MRI. Materials and methods: Between November 2023 and January 2025, 31 male patients with pelvic lymph node metastases were treated using this workflow. Daily MR scans were acquired in treatment position using a 1.5T MR scanner. Contours were adapted on 2D T2 turbo-spin-echo images, while synthetic CTs generated from T1 DIXON sequences were used for dose calculation. Adapted plans were delivered on a C-arm Linac using CBCT imaging for positioning. Quality assurance included independent Monte Carlo dose recalculations, automated plan parameters verification and a plan complexity check using in-house scripting. Results: Across 99 adapted fractions, plan adaptation improved dosimetric outcomes, with a median 14% increase in Planning Target Volume (PTV) coverage and a 7% reduction in bowel D1cc (dose to 1 cc). Median times for MR imaging, contouring, and planning were 12, 12, and 20 min, respectively. Conclusions: The Virtual MR-Linac approach enables high-quality ART to compensate for inter-fractional motion without the costs and complexity of integrated systems. It improves resource utilization, maintains patient comfort, and offers a flexible, scalable solution for clinical implementation.
- Open Access
- 22 March 2026
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 58, 101145
Accelerated radiotherapy pathways: a systematic review on same-day planning and treatment in radiation oncology
- 22 March 2026
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 58, 101145
Open AccessAccelerated radiotherapy pathways: a systematic review on same-day planning and treatment in radiation oncology
- Open Access
- 30 August 2025
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 35
A standardised workflow to manage the complexity of reirradiation and radiotherapy retreatments in clinical practice
- 30 August 2025
- Published by Elsevier in Technical Innovations & Patient Support in Radiation Oncology
- Vol. 35
Open AccessA standardised workflow to manage the complexity of reirradiation and radiotherapy retreatments in clinical practice
- Open Access
- 2 June 2025
- Published by Elsevier in Zeitschrift für Medizinische Physik
- Vol. 35 (4) , 423-427
Safety in MR-enhanced daily adaptive SBRT Radiotherapy using a conventional C-arm linear accelerator: An FMEA approach
- 2 June 2025
- Published by Elsevier in Zeitschrift für Medizinische Physik
- Vol. 35 (4) , 423-427
Open AccessSafety in MR-enhanced daily adaptive SBRT Radiotherapy using a conventional C-arm linear accelerator: An FMEA approach
- Open Access
- 27 April 2025
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 53, 100966
Same-Day Magnetic Resonance-Guided Single-Fraction Stereotactic Body Radiation Therapy for Painful Non-Spine Bone Metastases – A Single-Center Study (“BONE SHOT”)
- 27 April 2025
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 53, 100966
Open AccessSame-Day Magnetic Resonance-Guided Single-Fraction Stereotactic Body Radiation Therapy for Painful Non-Spine Bone Metastases – A Single-Center Study (“BONE SHOT”)
- Open Access
- 1 April 2023
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 40, 100624
Effect of 0.35 T and 1.5 T magnetic fields on superficial dose in MR-guided radiotherapy of laryngeal cancer
- 1 April 2023
- Published by Elsevier in Clinical and Translational Radiation Oncology
- Vol. 40, 100624
Open AccessEffect of 0.35 T and 1.5 T magnetic fields on superficial dose in MR-guided radiotherapy of laryngeal cancer
- Open Access
MR-Guided Adaptive Radiotherapy for Head and Neck Cancer: Prospective Evaluation of Migration and Anatomical Changes of the Major Salivary Glands
The aim of this study was to quantify anatomical changes of parotids and submandibular glands and evaluate potential dosimetric advantages during weekly adaptive MR-guided radiotherapy (MRgRT) for the definitive treatment of head and neck cancer (HNC). The data and plans of 12 patients treated with bilateral intensity-modulated radiotherapy for HNC using MR-linac, with weekly offline adaptations, were prospectively evaluated. The positional and volumetric changes of the salivary glands were analyzed by manual segmentation in weekly MRI images and the dosimetric impact of these anatomical changes on the adapted treatment plans was assessed. The mean volume change in parotid and submandibular gland volume was −31.9% (p < 0.0001) and −29.7% (p < 0.0001) after five weeks, respectively. The volume change was significantly correlated with the cumulative dose for the respective gland at the time of volume measurement. Inter-parotid distance changed by −5.4% (6.5 mm) on average after five weeks (p = 0.0005). The distance became significantly smaller only in the left-right direction. The inter-submandibular gland distance changed by 0.7 mm (p = 0.38). This study demonstrated significant changes in salivary gland volumes and position following daily MR guidance and weekly plan adaptation. Ongoing clinical trials will provide data on the clinical impact of these changes and novel MR-based adaptation strategies.
Open AccessMR-Guided Adaptive Radiotherapy for Head and Neck Cancer: Prospective Evaluation of Migration and Anatomical Changes of the Major Salivary Glands
The aim of this study was to quantify anatomical changes of parotids and submandibular glands and evaluate potential dosimetric advantages during weekly adaptive MR-guided radiotherapy (MRgRT) for the definitive treatment of head and neck cancer (HNC). The data and plans of 12 patients treated with bilateral intensity-modulated radiotherapy for HNC using MR-linac, with weekly offline adaptations, were prospectively evaluated. The positional and volumetric changes of the salivary glands were analyzed by manual segmentation in weekly MRI images and the dosimetric impact of these anatomical changes on the adapted treatment plans was assessed. The mean volume change in parotid and submandibular gland volume was −31.9% (p < 0.0001) and −29.7% (p < 0.0001) after five weeks, respectively. The volume change was significantly correlated with the cumulative dose for the respective gland at the time of volume measurement. Inter-parotid distance changed by −5.4% (6.5 mm) on average after five weeks (p = 0.0005). The distance became significantly smaller only in the left-right direction. The inter-submandibular gland distance changed by 0.7 mm (p = 0.38). This study demonstrated significant changes in salivary gland volumes and position following daily MR guidance and weekly plan adaptation. Ongoing clinical trials will provide data on the clinical impact of these changes and novel MR-based adaptation strategies.
- Open Access
- 26 September 2021
- Published by Springer Nature in Radiation Oncology
- Vol. 16 (1) , 1-7
Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer
Background: MR-guided online adaptive stereotactic body radiation therapy (SBRT) for prostate cancer aims to reduce toxicity by full compensation of interfractional uncertainties. However, the process of online adaptation currently takes approximately 45 min during which intrafractional movements remain unaccounted for. This study aims to analyze the dosimetric benefit of online adaptation and to evaluate its robustness over the duration of one treatment fraction. Methods: Baseline MR-scans at a MR-linear accelerator were acquired for ten healthy male volunteers for generation of mock-prostate SBRT plans with a dose prescription of 5 × 7.25 Gy. On a separate day, online MR-guided adaptation (ViewRay® MRIdian) was performed, and thereafter MR images were acquired every 15 min for 1 h to assess the stability of the adapted plan. Results: A dosimetric benefit of online MR-guided adaptive re-planning was observed in 90% of volunteers. The median D95CTV- and D95PTV-coverage was improved from 34.8 to 35.5 Gy and from 30.7 to 34.6 Gy, respectively. Improved target coverage was not associated with higher dose to the organs at risk, most importantly the rectum (median D1ccrectum baseline plan vs. adapted plan 33.3 Gy vs. 32.3 Gy). The benefit of online adaptation remained stable over 45 min for all volunteers. However, at 60 min, CTV-coverage was below a threshold of 32.5 Gy in 30% of volunteers (30.6 Gy, 32.0 Gy, 32.3 Gy). Conclusion: The dosimetric benefit of MR-guided online adaptation for prostate SBRT was robust over 45 min in all volunteers. However, intrafractional uncertainties became dosimetrically relevant at 60 min and we therefore recommend verification imaging before delivery of MR-guided online adapted SBRT.
- 26 September 2021
- Published by Springer Nature in Radiation Oncology
- Vol. 16 (1) , 1-7
Open AccessIntrafractional stability of MR-guided online adaptive SBRT for prostate cancer
Background: MR-guided online adaptive stereotactic body radiation therapy (SBRT) for prostate cancer aims to reduce toxicity by full compensation of interfractional uncertainties. However, the process of online adaptation currently takes approximately 45 min during which intrafractional movements remain unaccounted for. This study aims to analyze the dosimetric benefit of online adaptation and to evaluate its robustness over the duration of one treatment fraction. Methods: Baseline MR-scans at a MR-linear accelerator were acquired for ten healthy male volunteers for generation of mock-prostate SBRT plans with a dose prescription of 5 × 7.25 Gy. On a separate day, online MR-guided adaptation (ViewRay® MRIdian) was performed, and thereafter MR images were acquired every 15 min for 1 h to assess the stability of the adapted plan. Results: A dosimetric benefit of online MR-guided adaptive re-planning was observed in 90% of volunteers. The median D95CTV- and D95PTV-coverage was improved from 34.8 to 35.5 Gy and from 30.7 to 34.6 Gy, respectively. Improved target coverage was not associated with higher dose to the organs at risk, most importantly the rectum (median D1ccrectum baseline plan vs. adapted plan 33.3 Gy vs. 32.3 Gy). The benefit of online adaptation remained stable over 45 min for all volunteers. However, at 60 min, CTV-coverage was below a threshold of 32.5 Gy in 30% of volunteers (30.6 Gy, 32.0 Gy, 32.3 Gy). Conclusion: The dosimetric benefit of MR-guided online adaptation for prostate SBRT was robust over 45 min in all volunteers. However, intrafractional uncertainties became dosimetrically relevant at 60 min and we therefore recommend verification imaging before delivery of MR-guided online adapted SBRT.
- Open Access
- 1 July 2021
- Published by Springer Nature in Strahlentherapie und Onkologie
- Vol. 197 (9) , 836-846
Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose
Purpose: Dose, fractionation, normalization and the dose profile inside the target volume vary substantially in pulmonary stereotactic body radiotherapy (SBRT) between different institutions and SBRT technologies. Published planning studies have shown large variations of the mean dose in planning target volume (PTV) and gross tumor volume (GTV) or internal target volume (ITV) when dose prescription is performed to the PTV covering isodose. This planning study investigated whether dose prescription to the mean dose of the ITV improves consistency in pulmonary SBRT dose distributions. Materials and methods: This was a multi-institutional planning study by the German Society of Radiation Oncology (DEGRO) working group Radiosurgery and Stereotactic Radiotherapy. CT images and structures of ITV, PTV and all relevant organs at risk (OAR) for two patients with early stage non-small cell lung cancer (NSCLC) were distributed to all participating institutions. Each institute created a treatment plan with the technique commonly used in the institute for lung SBRT. The specified dose fractionation was 3 × 21.5 Gy normalized to the mean ITV dose. Additional dose objectives for target volumes and OAR were provided. Results: In all, 52 plans from 25 institutions were included in this analysis: 8 robotic radiosurgery (RRS), 34 intensity-modulated (MOD), and 10 3D-conformal (3D) radiation therapy plans. The distribution of the mean dose in the PTV did not differ significantly between the two patients (median 56.9 Gy vs 56.6 Gy). There was only a small difference between the techniques, with RRS having the lowest mean PTV dose with a median of 55.9 Gy followed by MOD plans with 56.7 Gy and 3D plans with 57.4 Gy having the highest. For the different organs at risk no significant difference between the techniques could be found. Conclusions: This planning study pointed out that multiparameter dose prescription including normalization on the mean ITV dose in combination with detailed objectives for the PTV and ITV achieve consistent dose distributions for peripheral lung tumors in combination with an ITV concept between different delivery techniques and across institutions.
- 1 July 2021
- Published by Springer Nature in Strahlentherapie und Onkologie
- Vol. 197 (9) , 836-846
Open AccessImproving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose
Purpose: Dose, fractionation, normalization and the dose profile inside the target volume vary substantially in pulmonary stereotactic body radiotherapy (SBRT) between different institutions and SBRT technologies. Published planning studies have shown large variations of the mean dose in planning target volume (PTV) and gross tumor volume (GTV) or internal target volume (ITV) when dose prescription is performed to the PTV covering isodose. This planning study investigated whether dose prescription to the mean dose of the ITV improves consistency in pulmonary SBRT dose distributions. Materials and methods: This was a multi-institutional planning study by the German Society of Radiation Oncology (DEGRO) working group Radiosurgery and Stereotactic Radiotherapy. CT images and structures of ITV, PTV and all relevant organs at risk (OAR) for two patients with early stage non-small cell lung cancer (NSCLC) were distributed to all participating institutions. Each institute created a treatment plan with the technique commonly used in the institute for lung SBRT. The specified dose fractionation was 3 × 21.5 Gy normalized to the mean ITV dose. Additional dose objectives for target volumes and OAR were provided. Results: In all, 52 plans from 25 institutions were included in this analysis: 8 robotic radiosurgery (RRS), 34 intensity-modulated (MOD), and 10 3D-conformal (3D) radiation therapy plans. The distribution of the mean dose in the PTV did not differ significantly between the two patients (median 56.9 Gy vs 56.6 Gy). There was only a small difference between the techniques, with RRS having the lowest mean PTV dose with a median of 55.9 Gy followed by MOD plans with 56.7 Gy and 3D plans with 57.4 Gy having the highest. For the different organs at risk no significant difference between the techniques could be found. Conclusions: This planning study pointed out that multiparameter dose prescription including normalization on the mean ITV dose in combination with detailed objectives for the PTV and ITV achieve consistent dose distributions for peripheral lung tumors in combination with an ITV concept between different delivery techniques and across institutions.
- Open Access
- 23 April 2021
- Published by Springer Nature in Strahlentherapie und Onkologie
- Vol. 197 (12) , 1093-1103
Head and neck radiotherapy on the MR linac: a multicenter planning challenge amongst MRIdian platform users
Purpose: Purpose of this study is to evaluate plan quality on the MRIdian (Viewray Inc., Oakwood Village, OH, USA) system for head and neck cancer (HNC) through comparison of planning approaches of several centers. Methods: A total of 14 planners using the MRIdian planning system participated in this treatment challenge, centrally organized by ViewRay, for one contoured case of oropharyngeal carcinoma with standard constraints for organs at risk (OAR). Homogeneity, conformity, sparing of OARs, and other parameters were evaluated according to The International Commission on Radiation Units and Measurements (ICRU) recommendations anonymously, and then compared between centers. Differences amongst centers were assessed by means of Wilcoxon test. Each plan had to fulfil hard constraints based on dose–volume histogram (DVH) parameters and delivery time. A plan quality metric (PQM) was evaluated. The PQM was defined as the sum of 16 submetrics characterizing different DVH goals. Results: For most dose parameters the median score of all centers was higher than the threshold that results in an ideal score. Six participants achieved the maximum number of points for the OAR dose parameters, and none had an unacceptable performance on any of the metrics. Each planner was able to achieve all the requirements except for one which exceeded delivery time. The number of segments correlated to improved PQM and inversely correlated to brainstem D0.1cc and to Planning Target Volume1 (PTV) D0.1cc. Total planning experience inversely correlated to spinal canal dose. Conclusion: Magnetic Resonance Image (MRI) linac-based planning for HNC is already feasible with good quality. Generally, an increased number of segments and increasing planning experience are able to provide better results regarding planning quality without significantly prolonging overall treatment time.
- 23 April 2021
- Published by Springer Nature in Strahlentherapie und Onkologie
- Vol. 197 (12) , 1093-1103
Open AccessHead and neck radiotherapy on the MR linac: a multicenter planning challenge amongst MRIdian platform users
Purpose: Purpose of this study is to evaluate plan quality on the MRIdian (Viewray Inc., Oakwood Village, OH, USA) system for head and neck cancer (HNC) through comparison of planning approaches of several centers. Methods: A total of 14 planners using the MRIdian planning system participated in this treatment challenge, centrally organized by ViewRay, for one contoured case of oropharyngeal carcinoma with standard constraints for organs at risk (OAR). Homogeneity, conformity, sparing of OARs, and other parameters were evaluated according to The International Commission on Radiation Units and Measurements (ICRU) recommendations anonymously, and then compared between centers. Differences amongst centers were assessed by means of Wilcoxon test. Each plan had to fulfil hard constraints based on dose–volume histogram (DVH) parameters and delivery time. A plan quality metric (PQM) was evaluated. The PQM was defined as the sum of 16 submetrics characterizing different DVH goals. Results: For most dose parameters the median score of all centers was higher than the threshold that results in an ideal score. Six participants achieved the maximum number of points for the OAR dose parameters, and none had an unacceptable performance on any of the metrics. Each planner was able to achieve all the requirements except for one which exceeded delivery time. The number of segments correlated to improved PQM and inversely correlated to brainstem D0.1cc and to Planning Target Volume1 (PTV) D0.1cc. Total planning experience inversely correlated to spinal canal dose. Conclusion: Magnetic Resonance Image (MRI) linac-based planning for HNC is already feasible with good quality. Generally, an increased number of segments and increasing planning experience are able to provide better results regarding planning quality without significantly prolonging overall treatment time.